CytoMed Therapeutics (GDTC) Minority Interest (2022 - 2025)
CytoMed Therapeutics (GDTC) posted Minority Interest of $75681.0 for Q2 2025, down 2.66% sequentially from $77749.0 in Q4 2024, and up 6973.84% YoY from $1069.9 in Q2 2024.
CytoMed Therapeutics (GDTC) Minority Interest (2022 - 2025) Analysis & Trends
CytoMed Therapeutics has reported Minority Interest for 4 years, with the latest figure at $75681.0 in Q2 2025.
- Quarterly Minority Interest rose 6973.84% year-over-year to $75681.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $75681.0 (up 6973.84% YoY) and the FY2024 annual result came in at $77749.0, up 8232.74% from the prior year.
- Minority Interest declined to $75681.0 in Q2 2025 per GDTC's latest filing, from $77749.0 in the prior quarter.
- Over five years, Minority Interest peaked at $77749.0 in Q4 2024 and troughed at -$1101.0 in Q2 2024.
- A 4-year average of $24978.2 and a median of -$752.0 in 2022 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2023 and 2024: Minority Interest sank 40.18% in 2023, then surged 8232.74% in 2024.
- Over 4 years, Minority Interest stood at -$682.0 in 2022, then slumped by 40.18% to -$956.0 in 2023, then soared by 8232.74% to $77749.0 in 2024, then retreated by 2.66% to $75681.0 in 2025.
- According to Business Quant data, Minority Interest over the past three periods registered $75681.0, $77749.0, and -$1101.0 for Q2 2025, Q4 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CytoMed Therapeutics | 10.72 Mn | 9.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 75,681.00 |
| Dec 31, 2024 | 77,749.00 |
| Jun 30, 2024 | -1,101.00 |
| Dec 31, 2023 | -956.00 |
| Jun 30, 2023 | -822.00 |
| Dec 31, 2022 | -682.00 |